Pharmaceuticals remain a draw for ESG investors
EdenTree’s Patel says industry’s response to Covid and innovation keep it attractive to ESG investors
Edentree
-
-
Three companies with environmental solutions
For World Environment Day, EdenTree’s Fitzgerald highlights Alfen, ADS and Veolia as leaders
-
ESG challenges and opportunities of IPOs
EdenTree’s Patel says reporting is an issue but there’s a chance to shape business sustainability
-
Thomas and Thomas Q&A: The ‘sticky money’ is going to ESG
Darren Lloyd Thomas shares how he builds ethical portfolios for clients and how being the son of a Baptist minister led him to ESG
-
Andy Clark: ‘ESG is not just about capabilities, but culture and character too’
EdenTree’s CEO discusses the perceived complexities around ESG investing, the firm’s culture and upcoming products
-
ESG funds struggle as economy emerges from pandemic
But over the long term they have successfully navigated the storm
-
Eden Tree launches impact bond fund and green future fund
EdenTree Investment Management has launched the EdenTree Global Impact Bond (GIB) Fund which aims to generate positive societal impact by investing in a global set of impact-oriented fixed income instruments. The fund’s philosophy is to drive capital towards issuers that make a net-positive impact. It will leverage public debt markets to help finance entities investing…
-
On the Move: ISSB appoints vice-chair and special adviser
Sue Lloyd and Janine Guillot join ISSB and PGIM hires ESG heads
-
Follow the science
EdenTree’s Ketan Patel reflects on the importance of aligning portfolios with science-based targets
-
On the Move: Schroders, Edison and Aegon hire for ESG teams
Seven groups announce ESG team appointments in October so far
-
$3.2trn investor group to target chemicals sector
ShareAction report poses questions for investors to ask in order for the sector to decarbonise
-
More companies must link executive pay with ESG commitments
Boohoo has accepted MPs’ recommendation to link bonuses with supply chain improvements